TQC3721 inhalation powder

TQC3721 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQC3721 inhalation powder, covering 2024-12-24 to 2024-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease [Phase 1]